0000939798-16-000109.txt : 20160219 0000939798-16-000109.hdr.sgml : 20160219 20160219171255 ACCESSION NUMBER: 0000939798-16-000109 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160219 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160219 DATE AS OF CHANGE: 20160219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 161442754 BUSINESS ADDRESS: STREET 1: 100 SOUTH ASHLEY DRIVE STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 100 SOUTH ASHLEY DRIVE STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 8-K 1 oxiseightk.htm OXIS 8-K AMENDMENT OF NOTE CONVERSION AGREEMENT oxiseightk.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 19, 2016

OXIS INTERNATIONAL, INC.
 (Exact name of Registrant as specified in its charter)
____________________

Delaware
(State or other Jurisdiction of Incorporation or organization)
000-08092
(Commission File Number)
94-1620407
(IRS Employer I.D. No.)
___________________________
 
100 South Ashley Drive
Suite 600
Tampa, FL 33602
Phone: (800) 304-9888
(Address, including zip code, and telephone and facsimile numbers, including area code, of
registrant’s executive offices)
___________________________

N/A
 
 (Former name, former address and former fiscal year, if changed since last report)


 

 
- 1 -

 



ITEM 1.01.
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
 
On February 19, 2016, Oxis International, Inc. (the “Company”) entered into an amendment (the “Amendment”) to that certain note conversion agreement dated January 8, 2016 (the “Conversion Agreement”).  As previously disclosed, under the Conversion Agreement, the investor parties thereto agreed to convert certain outstanding promissory notes into shares of the Company’s common stock upon the closing of a financing, as described in the Conversion Agreement, occurring on or before February 15, 2016.  The Amendment extends such deadline from February 15, 2016 to March 15, 2016.

The foregoing summary of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, which is attached hereto as Exhibits 10.1, and is incorporated herein by reference.

ITEM 8.01                                                OTHER EVENTS

On January 22, 2016, the Company filed a current report on Form 8-K disclosing the issuance of shares of common stock in exchange for the cancellation of warrants on a cashless basis.  Some of the persons who received common shares in exchange for the cancellation of warrants together with the number of common shares received by them are set forth on Exhibit 99.

ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS
 
(d)      Exhibits
     
Exhibit No.
  
Description
   
10.1
99
  
Form of Amendment to Note Conversion Agreement
Schedule of Certain Shareholders

SIGNATURE PAGE
 
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                                                                                                                                Oxis International, Inc.

Dated: February 19, 2016                                                                                                    By:    /s/ Anthony J. Cataldo
Anthony J. Cataldo,
Chief Executive Officer


EXHIBIT INDEX

     
Exhibit No.
  
Description
   
10.1
99
  
Form of Amendment to Note Conversion Agreement
Schedule of Certain Shareholders



 
- 2 -

 

EX-10.1 2 exhibittenone.htm FORM OF AMENDMENT TO NOTE CONVERSION AGREEMENT exhibittenone.htm
AMENDMENT TO
NOTE CONVERSION AGREEMENT

This Amendment to Note Conversion Agreement (this “Amendment”) is made effective as of February __, 2016 (the “Effective Date”) by and among OXIS International, Inc., a Delaware corporation (the “Company”), and each of the undersigned investors (each, an “Investor” and collectively, the “Investors”).
 
WHEREAS, the Company has previously entered into a Note Conversion Agreement dated January 8, 2016 (the “Note Conversion Agreement”) with each of the Investors pursuant to which the Investors have agreed to convert the Notes into Note Conversion Shares upon the closing of a Financing on or before the Financing Deadline, which is February 15, 2016.  All capitalized terms used but not defined herein shall have the meanings set forth in the Note Conversion Agreement.
 
WHEREAS, the Note Conversion Agreement provides that no provision of the Note Conversion Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Note Holders holding at least a majority in interest of the Note Conversion Shares then outstanding.
 
WHEREAS, the undersigned Investors constitute the Note Holders holding at least a majority in interest of the Note Conversion Shares.
 
WHEREAS, the Company and each of the Investors desire to extend the Financing Deadline set forth in the Note Conversion Agreement.
 
NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:
 
1. Extension of Financing Deadline.  The reference in Section 2(a) to a Financing Deadline of February 15, 2016 is hereby amended to change “February 15, 2016” to “March 15, 2016.”
 
2. Approval of Amendment.  By their signatures below, the Company and each Investor hereby adopt this Amendment.
 
3. Miscellaneous.
 
(a) Further Instruments and Acts.  Each party to this Amendment hereby agrees to perform any further acts and to execute and deliver any further documents that may be necessary or required to carry out the intent and provisions of this Amendment and the transactions contemplated hereby.
 
(b) Applicable Law; Entire Agreement.  This Amendment shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law.
 
(c) Continued Validity.  Except as otherwise expressly provided herein, the Note Conversion Agreement shall remain in full force and effect.
 
 
- 1 -

 
(d) Execution.  This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement, it being understood that the parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission or by email delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature was an original thereof.
 
 [REMAINDER OF PAGE LEFT INTENTIONALLY BLANK]
 

 

 
 
- 2 -

 

IN WITNESS WHEREOF, the Company has executed this Amendment as of the date first above written.
 
 
COMPANY:
 
OXIS INTERNATIONAL, INC.
 
 
By:                                                                
Name: _________________________________
Title: __________________________________
 
 
 

 

Signature page to
Amendment to Note Conversion Agreement
(Company)
 
 

 

IN WITNESS WHEREOF, the undersigned Investor has executed this Amendment as of the date first above written.
 
 
INVESTOR:
 
    If by an individual:
 
 
Printed Name: ___________________________
 
 
 
    If by an entity:
 
_______________________________________
Name of entity
 
By:                                                                
Printed Name: ___________________________
Title: __________________________________
 
 
   

 

Signature page to
Amendment to Note Conversion Agreement
(Investors)
 
 

 

EX-99 3 exhibitninetynine.htm LIST OF SOME CONVERTING WARRANTHOLDERS exhibitninetynine.htm
EXHIBIT 99
 
Warrantholder
Common Stock Issued
   
Adam Cohen
137,500
Alim Kassam
45,000
Blake Scheifele
27,500
Elan Zivotofsky
22,000
Farhad Rastanian
30,000
Ken Grebenstein
16,500
Richard Cohen
11,000
Sam Schlesinger
11,000
Theorem Group LLC
2,096,479